Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- California Retina Consultants
Bakersfield, California, United States
- Retina-Vitreous Associates Medical Group
Beverly Hills, California, United States
- Salehi Retina Institute Inc.
Huntington Beach, California, United States
- Bay Area Retina Associates
Walnut Creek, California, United States
- Advanced Vision Research Institute
Longmont, Colorado, United States
- Rand Eye Institute
Deerfield Beach, Florida, United States
- Florida Eye Associates
Melbourne, Florida, United States
- Retina Vitreous Associates of Florida
St. Petersburg, Florida, United States
- University Retina and Macula Associates
Lemont, Illinois, United States
- Midwest Eye
Carmel, Indiana, United States
- Cumberland Valley Retina Consultants
Hagerstown, Maryland, United States
- Sierra Eye Associates
Reno, Nevada, United States
- Eyehealth Northwest
Portland, Oregon, United States
- Erie Retina Research, Llc
Erie, Pennsylvania, United States
- Vision Research Solutions, Pllc
Philadelphia, Pennsylvania, United States
- Retina Consultants of Carolina
Greenville, South Carolina, United States
- Retina Research Institution of Texas
Abilene, Texas, United States
- Austin Retina Associates
Round Rock, Texas, United States
- Retina Center of Texas
Southlake, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 Aug 2023
- Primary completion
- 21 Jan 2025
- Completion
- 8 Apr 2025
- Last update posted
- 5 Aug 2025
- Registered enrollment
- 52
- Registry id
- NCT06011798
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.